SVRA: Savara Inc Kompaniya qiymatining sof foydaga nisbati
Joriy P/E koeffitsiyenti Savara Inc. (SVRA) kompaniyasining baholash dinamikasini ko'rsatadi, bunda -6.30 qiymati eng so'nggi raqamni ifodalaydi. Aksiyalar narxlari tadqiqot markazlari va shartnomaviy ishlab chiqarish zavodlarining barqaror faoliyati bilan qo'llab-quvvatlanmoqda. O'sish potentsiali yuqori erkin pul oqimini va'da qiluvchi Molgramostim ishlab chiqilishiga asoslangan. Kam uchraydigan kasalliklar hamjamiyatining kuchli ishonchi kompaniyaning o'pka uchun hayotiy muhim inhalatsiya terapiyalarini yaratuvchi maqomini tasdiqlaydi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_SVRA_-_Savara-Inc._-_PE-Multiple "SVRA: Savara Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 14.11.2026 | 👁️GURU.Markets👁️")
Savara Corp (SVRA) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Savara Inc.|SVRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Savara Pharma|SVRA - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Savara Inc.|SVRA - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Savara|Oraliq qoplama koeffitsiyenti savarapharma.com
- foyda va bozor multiplikatorlari tafsilotlari:
SVRA - Sof foyda|Prognoz qilingan kelajakdagi foyda Savara Inc.|SVRA - Narx-foyda koeffitsiyenti|Kelajakdagi narxning foydaga nisbati Savara Inc|SVRA - PEG multiplikatori|EV/EBITDA multiplikatori Savara Inc.|SVRA - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Savara|SVRA - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi savarapharma.com|SVRA - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Savara Inc.
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:savarapharma.com SVRA
Savara Inc. kamyob o'pka patologiyalarini davolash uchun mo'ljallangan orfan dori vositalarining tor segmentida faoliyat yuritadi, bu yerda terapiyaning yuqori xarajatlari kapitalizatsiyaga bevosita ta'sir ko'rsatadi. Kompaniyaning P/E ko'rsatkichini tahlil qilish orqali investor bozor qiymatining sof foydaga nisbati yordamida biznesning o'zini oqlash muddatini aniqlaydi, bu esa aktivning haddan tashqari qimmat baholanganligini aniqlash yoki uning fundamental jihatdan past baholanganligini tasdiqlash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati Tourmaline TRML|PGEN: P/E multiplikatori|pharming.com (PHAR) - P/E multiplikatori|Narx-foyda koeffitsiyenti NKTR|Narxning foydaga nisbati UPB|P/E multiplikatori ZBIO|P/E multiplikatori Immunome Bio (IMNM)|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|Kompaniya qiymatining sof foydaga nisbati KALV|Septerna - P/E multiplikatori|PVLA - P/E multiplikatori|RIGL (Rigel Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|AnaptysBio Inc. - Kompaniya qiymatining sof foydaga nisbati|ATXS (Astria Therapeutics) - P/E multiplikatori|engene.com (ENGN) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati RAPT Therapeutics (RAPT)|aerovatetx.com - Narx-foyda multiplikatori|P/E multiplikatori ACRS (Aclaris)|KYTX - Narx-foyda koeffitsiyenti|TLSA: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati cabalettabio.com CABA|Ventyx Biosciences, Inc. (VTYX) - Narxning foydaga nisbati|THTX - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti AVTX|Narxning foydaga nisbati ELDN|Narxning foydaga nisbati Agenus (AGEN)|CLYM (climbbio.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ZURA (Zura Bio)|P/E multiplikatori aTyr Pharma Inc ATYR|ADAG - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati IMA|STTK: P/E multiplikatori|Equillium - Kompaniya qiymatining sof foydaga nisbati|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|P/E multiplikatori Immunic Inc|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|IFRX (inflarx.de) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|ACET - Narx-foyda koeffitsiyenti|Celularity Corp - P/E multiplikatori|INMB - P/E multiplikatori|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kezar Life Sciences Inc - Kompaniya qiymatining sof foydaga nisbati|SABS (SAB Biotherapeutics) - P/E multiplikatori|akaritx.com (AKTX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Narx-foyda koeffitsiyenti q32bio.com QTTB|Narxning foydaga nisbati GeoVax Labs Inc GOVX|EDSA - Narx-foyda koeffitsiyenti|IBIO: Narx-foyda koeffitsiyenti|CARM - P/E multiplikatori|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda multiplikatori BOLT|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Aptevo APVO|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Biznesning o‘zini qoplash muddati aditxt.com|P/E multiplikatori GRI (GRI Bio)|P/E multiplikatori XORTX Therapeutics Inc XRTX|HIND: Narx-foyda koeffitsiyenti|REVB: Narxning foydaga nisbati|INDP: P/E multiplikatori|scinai.com (SCNI) - P/E multiplikatori|Narxning foydaga nisbati CalciMedica Inc|AFMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ALLK|P/E multiplikatori hookipapharma.com (HOOK)|IGM Biosciences - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati ITOS|Ocean Biomedical - P/E multiplikatori|Biznesning o‘zini qoplash muddati TC BioPharm (Holdings) Plc TCBP|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
